FindMyKOL
Clinical trialNCT04417062Active, not recruitingPhase 2Interventional

Olaparib With Ceralasertib in Recurrent Osteosarcoma

SponsorDana-Farber Cancer InstituteEnrollment49OsteosarcomaOsteosarcoma Recurrent
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is being done in order to evaluate the effectiveness of using two drugs (olaparib and ceralasertib) to treat patients with osteosarcoma that has not responded to treatment or has come back after treatment The names of the study drugs involved in this study are: * Olaparib * Ceralasertib
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsf Benioff Children'S Hospital; Ucsf Pediatrics Hematology Oncology

    San Francisco, California, United States

  • Dana Farber Cancer Institite

    Boston, Massachusetts, United States

  • Memorial Sloan Kettering

    New York, New York, United States

  • Md Anderson

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

CeralasertibOlaparib →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
24 Nov 2020
Primary completion
1 Jun 2025
Completion
1 Dec 2026
Last update posted
20 Aug 2026
Registered enrollment
49
Registry id
NCT04417062
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.